<?xml version="1.0" encoding="UTF-8"  standalone="no" ?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-02-21" modified="2024-10-02" version="184" xmlns="http://uniprot.org/uniprot">
  <accession>Q9Y6K5</accession>
  <accession>Q2HJ14</accession>
  <accession>Q9H3P5</accession>
  <name>OAS3_HUMAN</name>
  <protein>
    <recommendedName>
      <fullName>2'-5'-oligoadenylate synthase 3</fullName>
      <shortName>(2-5')oligo(A) synthase 3</shortName>
      <shortName>2-5A synthase 3</shortName>
      <ecNumber evidence="7 8">2.7.7.84</ecNumber>
    </recommendedName>
    <alternativeName>
      <fullName>p100 OAS</fullName>
      <shortName>p100OAS</shortName>
    </alternativeName>
  </protein>
  <gene>
    <name type="primary">OAS3</name>
    <name type="ORF">P/OKcl.4</name>
  </gene>
  <organism>
    <name type="scientific">Homo sapiens</name>
    <name type="common">Human</name>
    <dbReference type="NCBI Taxonomy" id="9606"/>
    <lineage>
      <taxon>Eukaryota</taxon>
      <taxon>Metazoa</taxon>
      <taxon>Chordata</taxon>
      <taxon>Craniata</taxon>
      <taxon>Vertebrata</taxon>
      <taxon>Euteleostomi</taxon>
      <taxon>Mammalia</taxon>
      <taxon>Eutheria</taxon>
      <taxon>Euarchontoglires</taxon>
      <taxon>Primates</taxon>
      <taxon>Haplorrhini</taxon>
      <taxon>Catarrhini</taxon>
      <taxon>Hominidae</taxon>
      <taxon>Homo</taxon>
    </lineage>
  </organism>
  <reference key="1">
    <citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="1557" last="1565">
      <title>The 100-kDa 2',5'-oligoadenylate synthetase catalyzing preferentially the synthesis of dimeric pppA2'p5'A molecules is composed of three homologous domains.</title>
      <authorList>
        <person name="Rebouillat D."/>
        <person name="Hovnanian A."/>
        <person name="Marie I."/>
        <person name="Hovanessian A.G."/>
      </authorList>
      <dbReference type="PubMed" id="9880533"/>
      <dbReference type="DOI" id="10.1074/jbc.274.3.1557"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <scope>PARTIAL PROTEIN SEQUENCE</scope>
    <scope>FUNCTION</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>COFACTOR</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="2">
    <citation type="journal article" date="2001" name="Cancer Res." volume="61" first="2038" last="2046">
      <title>Molecular basis of T cell-mediated recognition of pancreatic cancer cells.</title>
      <authorList>
        <person name="Ito M."/>
        <person name="Shichijo S."/>
        <person name="Tsuda N."/>
        <person name="Ochi M."/>
        <person name="Harashima N."/>
        <person name="Saito N."/>
        <person name="Itoh K."/>
      </authorList>
      <dbReference type="PubMed" id="11280764"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
    <scope>VARIANT LYS-18</scope>
    <source>
      <tissue>Pancreatic cancer</tissue>
    </source>
  </reference>
  <reference key="3">
    <citation type="journal article" date="2006" name="Nature" volume="440" first="346" last="351">
      <title>The finished DNA sequence of human chromosome 12.</title>
      <authorList>
        <person name="Scherer S.E."/>
        <person name="Muzny D.M."/>
        <person name="Buhay C.J."/>
        <person name="Chen R."/>
        <person name="Cree A."/>
        <person name="Ding Y."/>
        <person name="Dugan-Rocha S."/>
        <person name="Gill R."/>
        <person name="Gunaratne P."/>
        <person name="Harris R.A."/>
        <person name="Hawes A.C."/>
        <person name="Hernandez J."/>
        <person name="Hodgson A.V."/>
        <person name="Hume J."/>
        <person name="Jackson A."/>
        <person name="Khan Z.M."/>
        <person name="Kovar-Smith C."/>
        <person name="Lewis L.R."/>
        <person name="Lozado R.J."/>
        <person name="Metzker M.L."/>
        <person name="Milosavljevic A."/>
        <person name="Miner G.R."/>
        <person name="Montgomery K.T."/>
        <person name="Morgan M.B."/>
        <person name="Nazareth L.V."/>
        <person name="Scott G."/>
        <person name="Sodergren E."/>
        <person name="Song X.-Z."/>
        <person name="Steffen D."/>
        <person name="Lovering R.C."/>
        <person name="Wheeler D.A."/>
        <person name="Worley K.C."/>
        <person name="Yuan Y."/>
        <person name="Zhang Z."/>
        <person name="Adams C.Q."/>
        <person name="Ansari-Lari M.A."/>
        <person name="Ayele M."/>
        <person name="Brown M.J."/>
        <person name="Chen G."/>
        <person name="Chen Z."/>
        <person name="Clerc-Blankenburg K.P."/>
        <person name="Davis C."/>
        <person name="Delgado O."/>
        <person name="Dinh H.H."/>
        <person name="Draper H."/>
        <person name="Gonzalez-Garay M.L."/>
        <person name="Havlak P."/>
        <person name="Jackson L.R."/>
        <person name="Jacob L.S."/>
        <person name="Kelly S.H."/>
        <person name="Li L."/>
        <person name="Li Z."/>
        <person name="Liu J."/>
        <person name="Liu W."/>
        <person name="Lu J."/>
        <person name="Maheshwari M."/>
        <person name="Nguyen B.-V."/>
        <person name="Okwuonu G.O."/>
        <person name="Pasternak S."/>
        <person name="Perez L.M."/>
        <person name="Plopper F.J.H."/>
        <person name="Santibanez J."/>
        <person name="Shen H."/>
        <person name="Tabor P.E."/>
        <person name="Verduzco D."/>
        <person name="Waldron L."/>
        <person name="Wang Q."/>
        <person name="Williams G.A."/>
        <person name="Zhang J."/>
        <person name="Zhou J."/>
        <person name="Allen C.C."/>
        <person name="Amin A.G."/>
        <person name="Anyalebechi V."/>
        <person name="Bailey M."/>
        <person name="Barbaria J.A."/>
        <person name="Bimage K.E."/>
        <person name="Bryant N.P."/>
        <person name="Burch P.E."/>
        <person name="Burkett C.E."/>
        <person name="Burrell K.L."/>
        <person name="Calderon E."/>
        <person name="Cardenas V."/>
        <person name="Carter K."/>
        <person name="Casias K."/>
        <person name="Cavazos I."/>
        <person name="Cavazos S.R."/>
        <person name="Ceasar H."/>
        <person name="Chacko J."/>
        <person name="Chan S.N."/>
        <person name="Chavez D."/>
        <person name="Christopoulos C."/>
        <person name="Chu J."/>
        <person name="Cockrell R."/>
        <person name="Cox C.D."/>
        <person name="Dang M."/>
        <person name="Dathorne S.R."/>
        <person name="David R."/>
        <person name="Davis C.M."/>
        <person name="Davy-Carroll L."/>
        <person name="Deshazo D.R."/>
        <person name="Donlin J.E."/>
        <person name="D'Souza L."/>
        <person name="Eaves K.A."/>
        <person name="Egan A."/>
        <person name="Emery-Cohen A.J."/>
        <person name="Escotto M."/>
        <person name="Flagg N."/>
        <person name="Forbes L.D."/>
        <person name="Gabisi A.M."/>
        <person name="Garza M."/>
        <person name="Hamilton C."/>
        <person name="Henderson N."/>
        <person name="Hernandez O."/>
        <person name="Hines S."/>
        <person name="Hogues M.E."/>
        <person name="Huang M."/>
        <person name="Idlebird D.G."/>
        <person name="Johnson R."/>
        <person name="Jolivet A."/>
        <person name="Jones S."/>
        <person name="Kagan R."/>
        <person name="King L.M."/>
        <person name="Leal B."/>
        <person name="Lebow H."/>
        <person name="Lee S."/>
        <person name="LeVan J.M."/>
        <person name="Lewis L.C."/>
        <person name="London P."/>
        <person name="Lorensuhewa L.M."/>
        <person name="Loulseged H."/>
        <person name="Lovett D.A."/>
        <person name="Lucier A."/>
        <person name="Lucier R.L."/>
        <person name="Ma J."/>
        <person name="Madu R.C."/>
        <person name="Mapua P."/>
        <person name="Martindale A.D."/>
        <person name="Martinez E."/>
        <person name="Massey E."/>
        <person name="Mawhiney S."/>
        <person name="Meador M.G."/>
        <person name="Mendez S."/>
        <person name="Mercado C."/>
        <person name="Mercado I.C."/>
        <person name="Merritt C.E."/>
        <person name="Miner Z.L."/>
        <person name="Minja E."/>
        <person name="Mitchell T."/>
        <person name="Mohabbat F."/>
        <person name="Mohabbat K."/>
        <person name="Montgomery B."/>
        <person name="Moore N."/>
        <person name="Morris S."/>
        <person name="Munidasa M."/>
        <person name="Ngo R.N."/>
        <person name="Nguyen N.B."/>
        <person name="Nickerson E."/>
        <person name="Nwaokelemeh O.O."/>
        <person name="Nwokenkwo S."/>
        <person name="Obregon M."/>
        <person name="Oguh M."/>
        <person name="Oragunye N."/>
        <person name="Oviedo R.J."/>
        <person name="Parish B.J."/>
        <person name="Parker D.N."/>
        <person name="Parrish J."/>
        <person name="Parks K.L."/>
        <person name="Paul H.A."/>
        <person name="Payton B.A."/>
        <person name="Perez A."/>
        <person name="Perrin W."/>
        <person name="Pickens A."/>
        <person name="Primus E.L."/>
        <person name="Pu L.-L."/>
        <person name="Puazo M."/>
        <person name="Quiles M.M."/>
        <person name="Quiroz J.B."/>
        <person name="Rabata D."/>
        <person name="Reeves K."/>
        <person name="Ruiz S.J."/>
        <person name="Shao H."/>
        <person name="Sisson I."/>
        <person name="Sonaike T."/>
        <person name="Sorelle R.P."/>
        <person name="Sutton A.E."/>
        <person name="Svatek A.F."/>
        <person name="Svetz L.A."/>
        <person name="Tamerisa K.S."/>
        <person name="Taylor T.R."/>
        <person name="Teague B."/>
        <person name="Thomas N."/>
        <person name="Thorn R.D."/>
        <person name="Trejos Z.Y."/>
        <person name="Trevino B.K."/>
        <person name="Ukegbu O.N."/>
        <person name="Urban J.B."/>
        <person name="Vasquez L.I."/>
        <person name="Vera V.A."/>
        <person name="Villasana D.M."/>
        <person name="Wang L."/>
        <person name="Ward-Moore S."/>
        <person name="Warren J.T."/>
        <person name="Wei X."/>
        <person name="White F."/>
        <person name="Williamson A.L."/>
        <person name="Wleczyk R."/>
        <person name="Wooden H.S."/>
        <person name="Wooden S.H."/>
        <person name="Yen J."/>
        <person name="Yoon L."/>
        <person name="Yoon V."/>
        <person name="Zorrilla S.E."/>
        <person name="Nelson D."/>
        <person name="Kucherlapati R."/>
        <person name="Weinstock G."/>
        <person name="Gibbs R.A."/>
      </authorList>
      <dbReference type="PubMed" id="16541075"/>
      <dbReference type="DOI" id="10.1038/nature04569"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
  </reference>
  <reference key="4">
    <citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
      <title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
      <authorList>
        <consortium name="The MGC Project Team"/>
      </authorList>
      <dbReference type="PubMed" id="15489334"/>
      <dbReference type="DOI" id="10.1101/gr.2596504"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
    <scope>VARIANT ARG-381</scope>
    <source>
      <tissue>Brain</tissue>
    </source>
  </reference>
  <reference key="5">
    <citation type="journal article" date="2000" name="Genomics" volume="70" first="232" last="240">
      <title>Characterization of the gene encoding the 100-kDa form of human 2', 5'oligoadenylate synthetase.</title>
      <authorList>
        <person name="Rebouillat D."/>
        <person name="Hovnanian A."/>
        <person name="David G."/>
        <person name="Hovanessian A.G."/>
        <person name="Williams B.R."/>
      </authorList>
      <dbReference type="PubMed" id="11112351"/>
      <dbReference type="DOI" id="10.1006/geno.2000.6382"/>
    </citation>
    <scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-59</scope>
    <source>
      <tissue>Monocyte</tissue>
    </source>
  </reference>
  <reference key="6">
    <citation type="submission" date="2009-06" db="UniProtKB">
      <authorList>
        <person name="Bienvenut W.V."/>
        <person name="Gao M."/>
        <person name="Leug H."/>
      </authorList>
    </citation>
    <scope>PROTEIN SEQUENCE OF 1-17; 118-132; 244-253 AND 371-378</scope>
    <scope>ACETYLATION AT MET-1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
    <source>
      <tissue>Prostatic carcinoma</tissue>
    </source>
  </reference>
  <reference key="7">
    <citation type="journal article" date="2007" name="Biochimie" volume="89" first="779" last="788">
      <title>The human 2'-5'oligoadenylate synthetase family: unique interferon-inducible enzymes catalyzing 2'-5' instead of 3'-5' phosphodiester bond formation.</title>
      <authorList>
        <person name="Hovanessian A.G."/>
        <person name="Justesen J."/>
      </authorList>
      <dbReference type="PubMed" id="17408844"/>
      <dbReference type="DOI" id="10.1016/j.biochi.2007.02.003"/>
    </citation>
    <scope>REVIEW ON FUNCTION</scope>
  </reference>
  <reference key="8">
    <citation type="journal article" date="2009" name="J. Immunol." volume="183" first="8035" last="8043">
      <title>Distinct antiviral roles for human 2',5'-oligoadenylate synthetase family members against dengue virus infection.</title>
      <authorList>
        <person name="Lin R.J."/>
        <person name="Yu H.P."/>
        <person name="Chang B.L."/>
        <person name="Tang W.C."/>
        <person name="Liao C.L."/>
        <person name="Lin Y.L."/>
      </authorList>
      <dbReference type="PubMed" id="19923450"/>
      <dbReference type="DOI" id="10.4049/jimmunol.0902728"/>
    </citation>
    <scope>FUNCTION</scope>
    <scope>SUBCELLULAR LOCATION</scope>
  </reference>
  <reference key="9">
    <citation type="journal article" date="2009" name="J. Mol. Evol." volume="69" first="612" last="624">
      <title>Evolution of the 2'-5'-oligoadenylate synthetase family in eukaryotes and bacteria.</title>
      <authorList>
        <person name="Kjaer K.H."/>
        <person name="Poulsen J.B."/>
        <person name="Reintamm T."/>
        <person name="Saby E."/>
        <person name="Martensen P.M."/>
        <person name="Kelve M."/>
        <person name="Justesen J."/>
      </authorList>
      <dbReference type="PubMed" id="19904482"/>
      <dbReference type="DOI" id="10.1007/s00239-009-9299-1"/>
    </citation>
    <scope>REVIEW</scope>
  </reference>
  <reference key="10">
    <citation type="journal article" date="2009" name="Virology" volume="384" first="216" last="222">
      <title>The large form of human 2',5'-Oligoadenylate Synthetase (OAS3) exerts antiviral effect against Chikungunya virus.</title>
      <authorList>
        <person name="Brehin A.C."/>
        <person name="Casademont I."/>
        <person name="Frenkiel M.P."/>
        <person name="Julier C."/>
        <person name="Sakuntabhai A."/>
        <person name="Despres P."/>
      </authorList>
      <dbReference type="PubMed" id="19056102"/>
      <dbReference type="DOI" id="10.1016/j.virol.2008.10.021"/>
    </citation>
    <scope>FUNCTION</scope>
  </reference>
  <reference key="11">
    <citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
      <title>Initial characterization of the human central proteome.</title>
      <authorList>
        <person name="Burkard T.R."/>
        <person name="Planyavsky M."/>
        <person name="Kaupe I."/>
        <person name="Breitwieser F.P."/>
        <person name="Buerckstuemmer T."/>
        <person name="Bennett K.L."/>
        <person name="Superti-Furga G."/>
        <person name="Colinge J."/>
      </authorList>
      <dbReference type="PubMed" id="21269460"/>
      <dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
    </citation>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="12">
    <citation type="journal article" date="2011" name="J. Interferon Cytokine Res." volume="31" first="41" last="47">
      <title>The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities.</title>
      <authorList>
        <person name="Kristiansen H."/>
        <person name="Gad H.H."/>
        <person name="Eskildsen-Larsen S."/>
        <person name="Despres P."/>
        <person name="Hartmann R."/>
      </authorList>
      <dbReference type="PubMed" id="21142819"/>
      <dbReference type="DOI" id="10.1089/jir.2010.0107"/>
    </citation>
    <scope>REVIEW ON FUNCTION</scope>
  </reference>
  <reference key="13">
    <citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
      <title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
      <authorList>
        <person name="Van Damme P."/>
        <person name="Lasa M."/>
        <person name="Polevoda B."/>
        <person name="Gazquez C."/>
        <person name="Elosegui-Artola A."/>
        <person name="Kim D.S."/>
        <person name="De Juan-Pardo E."/>
        <person name="Demeyer K."/>
        <person name="Hole K."/>
        <person name="Larrea E."/>
        <person name="Timmerman E."/>
        <person name="Prieto J."/>
        <person name="Arnesen T."/>
        <person name="Sherman F."/>
        <person name="Gevaert K."/>
        <person name="Aldabe R."/>
      </authorList>
      <dbReference type="PubMed" id="22814378"/>
      <dbReference type="DOI" id="10.1073/pnas.1210303109"/>
    </citation>
    <scope>ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
  </reference>
  <reference key="14">
    <citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
      <title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
      <authorList>
        <person name="Zhou H."/>
        <person name="Di Palma S."/>
        <person name="Preisinger C."/>
        <person name="Peng M."/>
        <person name="Polat A.N."/>
        <person name="Heck A.J."/>
        <person name="Mohammed S."/>
      </authorList>
      <dbReference type="PubMed" id="23186163"/>
      <dbReference type="DOI" id="10.1021/pr300630k"/>
    </citation>
    <scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-365</scope>
    <scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
    <source>
      <tissue>Cervix carcinoma</tissue>
    </source>
  </reference>
  <reference key="15">
    <citation type="journal article" date="2015" name="Proc. Natl. Acad. Sci. U.S.A." volume="112" first="3949" last="3954">
      <title>Structural mechanism of sensing long dsRNA via a noncatalytic domain in human oligoadenylate synthetase 3.</title>
      <authorList>
        <person name="Donovan J."/>
        <person name="Whitney G."/>
        <person name="Rath S."/>
        <person name="Korennykh A."/>
      </authorList>
      <dbReference type="PubMed" id="25775560"/>
      <dbReference type="DOI" id="10.1073/pnas.1419409112"/>
    </citation>
    <scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1-371 IN COMPLEX WITH DSRNA</scope>
    <scope>CATALYTIC ACTIVITY</scope>
    <scope>SUBUNIT</scope>
    <scope>DOMAIN</scope>
    <scope>MUTAGENESIS OF ARG-30; ARG-41; GLU-76; SER-145 AND 816-ASP--ASP-818</scope>
  </reference>
  <comment type="function">
    <text evidence="5 6 8">Interferon-induced, dsRNA-activated antiviral enzyme which plays a critical role in cellular innate antiviral response. In addition, it may also play a role in other cellular processes such as apoptosis, cell growth, differentiation and gene regulation. Synthesizes preferentially dimers of 2'-5'-oligoadenylates (2-5A) from ATP which then bind to the inactive monomeric form of ribonuclease L (RNase L) leading to its dimerization and subsequent activation. Activation of RNase L leads to degradation of cellular as well as viral RNA, resulting in the inhibition of protein synthesis, thus terminating viral replication. Can mediate the antiviral effect via the classical RNase L-dependent pathway or an alternative antiviral pathway independent of RNase L. Displays antiviral activity against Chikungunya virus (CHIKV), Dengue virus, Sindbis virus (SINV) and Semliki forest virus (SFV).</text>
  </comment>
  <comment type="catalytic activity">
    <reaction evidence="7 8">
      <text>3 ATP = 5'-triphosphoadenylyl-(2'-&gt;5')-adenylyl-(2'-&gt;5')-adenosine + 2 diphosphate</text>
      <dbReference type="Rhea" id="RHEA:34407"/>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
      <dbReference type="ChEBI" id="CHEBI:33019"/>
      <dbReference type="ChEBI" id="CHEBI:67143"/>
      <dbReference type="EC" id="2.7.7.84"/>
    </reaction>
  </comment>
  <comment type="cofactor">
    <cofactor evidence="12">
      <name>Mg(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:18420"/>
    </cofactor>
  </comment>
  <comment type="activity regulation">
    <text evidence="7 10">Produced as a latent enzyme which is activated by dsRNA generated during the course of viral infection (Probable). Strongly activated by long dsRNAs at least 50 nucleotides in length (PubMed:25775560). ssRNA does not activate the enzyme (PubMed:25775560).</text>
  </comment>
  <comment type="subunit">
    <text evidence="7">Monomer.</text>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6115729">
      <id>Q9Y6K5</id>
    </interactant>
    <interactant intactId="EBI-1211456">
      <id>Q7L2E3</id>
      <label>DHX30</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6115729">
      <id>Q9Y6K5</id>
    </interactant>
    <interactant intactId="EBI-372243">
      <id>P56537</id>
      <label>EIF6</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6115729">
      <id>Q9Y6K5</id>
    </interactant>
    <interactant intactId="EBI-744088">
      <id>Q8IY81</id>
      <label>FTSJ3</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6115729">
      <id>Q9Y6K5</id>
    </interactant>
    <interactant intactId="EBI-2512448">
      <id>Q12894</id>
      <label>IFRD2</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="interaction">
    <interactant intactId="EBI-6115729">
      <id>Q9Y6K5</id>
    </interactant>
    <interactant intactId="EBI-995373">
      <id>Q7Z434</id>
      <label>MAVS</label>
    </interactant>
    <organismsDiffer>false</organismsDiffer>
    <experiments>2</experiments>
  </comment>
  <comment type="subcellular location">
    <subcellularLocation>
      <location>Cytoplasm</location>
    </subcellularLocation>
    <subcellularLocation>
      <location>Nucleus</location>
    </subcellularLocation>
  </comment>
  <comment type="tissue specificity">
    <text>Present at high level in placenta trophoblast.</text>
  </comment>
  <comment type="induction">
    <text>By type I interferon (IFN) and viruses.</text>
  </comment>
  <comment type="domain">
    <text evidence="7">OAS domain 3 is catalytically active. OAS domain 1 has no catalytic activity but is essential for recognition of long dsRNAs.</text>
  </comment>
  <comment type="similarity">
    <text evidence="10">Belongs to the 2-5A synthase family.</text>
  </comment>
  <comment type="sequence caution" evidence="10">
    <conflict type="frameshift">
      <sequence resource="EMBL-CDS" id="AAD28543" version="1"/>
    </conflict>
  </comment>
  <dbReference type="EC" id="2.7.7.84" evidence="7 8"/>
  <dbReference type="EMBL" id="AF063613">
    <property type="protein sequence ID" value="AAD28543.1"/>
    <property type="status" value="ALT_FRAME"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AB044545">
    <property type="protein sequence ID" value="BAB18647.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AC004551">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="EMBL" id="BC113746">
    <property type="protein sequence ID" value="AAI13747.1"/>
    <property type="molecule type" value="mRNA"/>
  </dbReference>
  <dbReference type="EMBL" id="AF251351">
    <property type="status" value="NOT_ANNOTATED_CDS"/>
    <property type="molecule type" value="Genomic_DNA"/>
  </dbReference>
  <dbReference type="CCDS" id="CCDS44981.1"/>
  <dbReference type="RefSeq" id="NP_006178.2">
    <property type="nucleotide sequence ID" value="NM_006187.3"/>
  </dbReference>
  <dbReference type="PDB" id="4S3N">
    <property type="method" value="X-ray"/>
    <property type="resolution" value="2.00 A"/>
    <property type="chains" value="A=1-371"/>
  </dbReference>
  <dbReference type="PDBsum" id="4S3N"/>
  <dbReference type="AlphaFoldDB" id="Q9Y6K5"/>
  <dbReference type="SMR" id="Q9Y6K5"/>
  <dbReference type="BioGRID" id="110994">
    <property type="interactions" value="65"/>
  </dbReference>
  <dbReference type="IntAct" id="Q9Y6K5">
    <property type="interactions" value="43"/>
  </dbReference>
  <dbReference type="MINT" id="Q9Y6K5"/>
  <dbReference type="STRING" id="9606.ENSP00000228928"/>
  <dbReference type="GlyGen" id="Q9Y6K5">
    <property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
  </dbReference>
  <dbReference type="iPTMnet" id="Q9Y6K5"/>
  <dbReference type="PhosphoSitePlus" id="Q9Y6K5"/>
  <dbReference type="SwissPalm" id="Q9Y6K5"/>
  <dbReference type="BioMuta" id="OAS3"/>
  <dbReference type="DMDM" id="317373408"/>
  <dbReference type="jPOST" id="Q9Y6K5"/>
  <dbReference type="MassIVE" id="Q9Y6K5"/>
  <dbReference type="PaxDb" id="9606-ENSP00000228928"/>
  <dbReference type="PeptideAtlas" id="Q9Y6K5"/>
  <dbReference type="ProteomicsDB" id="86712"/>
  <dbReference type="Pumba" id="Q9Y6K5"/>
  <dbReference type="Antibodypedia" id="31208">
    <property type="antibodies" value="218 antibodies from 33 providers"/>
  </dbReference>
  <dbReference type="DNASU" id="4940"/>
  <dbReference type="Ensembl" id="ENST00000228928.12">
    <property type="protein sequence ID" value="ENSP00000228928.7"/>
    <property type="gene ID" value="ENSG00000111331.14"/>
  </dbReference>
  <dbReference type="GeneID" id="4940"/>
  <dbReference type="KEGG" id="hsa:4940"/>
  <dbReference type="MANE-Select" id="ENST00000228928.12">
    <property type="protein sequence ID" value="ENSP00000228928.7"/>
    <property type="RefSeq nucleotide sequence ID" value="NM_006187.4"/>
    <property type="RefSeq protein sequence ID" value="NP_006178.2"/>
  </dbReference>
  <dbReference type="UCSC" id="uc001tug.4">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="AGR" id="HGNC:8088"/>
  <dbReference type="CTD" id="4940"/>
  <dbReference type="DisGeNET" id="4940"/>
  <dbReference type="GeneCards" id="OAS3"/>
  <dbReference type="HGNC" id="HGNC:8088">
    <property type="gene designation" value="OAS3"/>
  </dbReference>
  <dbReference type="HPA" id="ENSG00000111331">
    <property type="expression patterns" value="Low tissue specificity"/>
  </dbReference>
  <dbReference type="MIM" id="603351">
    <property type="type" value="gene"/>
  </dbReference>
  <dbReference type="neXtProt" id="NX_Q9Y6K5"/>
  <dbReference type="OpenTargets" id="ENSG00000111331"/>
  <dbReference type="PharmGKB" id="PA31877"/>
  <dbReference type="VEuPathDB" id="HostDB:ENSG00000111331"/>
  <dbReference type="eggNOG" id="ENOG502S649">
    <property type="taxonomic scope" value="Eukaryota"/>
  </dbReference>
  <dbReference type="GeneTree" id="ENSGT00510000046406"/>
  <dbReference type="HOGENOM" id="CLU_287245_0_0_1"/>
  <dbReference type="InParanoid" id="Q9Y6K5"/>
  <dbReference type="OMA" id="WQDPVPG"/>
  <dbReference type="OrthoDB" id="4638494at2759"/>
  <dbReference type="PhylomeDB" id="Q9Y6K5"/>
  <dbReference type="TreeFam" id="TF329749"/>
  <dbReference type="BioCyc" id="MetaCyc:ENSG00000111331-MONOMER"/>
  <dbReference type="BRENDA" id="2.7.7.84">
    <property type="organism ID" value="2681"/>
  </dbReference>
  <dbReference type="PathwayCommons" id="Q9Y6K5"/>
  <dbReference type="Reactome" id="R-HSA-877300">
    <property type="pathway name" value="Interferon gamma signaling"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-8983711">
    <property type="pathway name" value="OAS antiviral response"/>
  </dbReference>
  <dbReference type="Reactome" id="R-HSA-909733">
    <property type="pathway name" value="Interferon alpha/beta signaling"/>
  </dbReference>
  <dbReference type="SignaLink" id="Q9Y6K5"/>
  <dbReference type="BioGRID-ORCS" id="4940">
    <property type="hits" value="8 hits in 1170 CRISPR screens"/>
  </dbReference>
  <dbReference type="ChiTaRS" id="OAS3">
    <property type="organism name" value="human"/>
  </dbReference>
  <dbReference type="EvolutionaryTrace" id="Q9Y6K5"/>
  <dbReference type="GeneWiki" id="OAS3"/>
  <dbReference type="GenomeRNAi" id="4940"/>
  <dbReference type="Pharos" id="Q9Y6K5">
    <property type="development level" value="Tbio"/>
  </dbReference>
  <dbReference type="PRO" id="PR:Q9Y6K5"/>
  <dbReference type="Proteomes" id="UP000005640">
    <property type="component" value="Chromosome 12"/>
  </dbReference>
  <dbReference type="RNAct" id="Q9Y6K5">
    <property type="molecule type" value="protein"/>
  </dbReference>
  <dbReference type="Bgee" id="ENSG00000111331">
    <property type="expression patterns" value="Expressed in monocyte and 157 other cell types or tissues"/>
  </dbReference>
  <dbReference type="ExpressionAtlas" id="Q9Y6K5">
    <property type="expression patterns" value="baseline and differential"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005737">
    <property type="term" value="C:cytoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005829">
    <property type="term" value="C:cytosol"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005615">
    <property type="term" value="C:extracellular space"/>
    <property type="evidence" value="ECO:0007005"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0043231">
    <property type="term" value="C:intracellular membrane-bounded organelle"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0016020">
    <property type="term" value="C:membrane"/>
    <property type="evidence" value="ECO:0000318"/>
    <property type="project" value="GO_Central"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005654">
    <property type="term" value="C:nucleoplasm"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005886">
    <property type="term" value="C:plasma membrane"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="HPA"/>
  </dbReference>
  <dbReference type="GO" id="GO:0001730">
    <property type="term" value="F:2'-5'-oligoadenylate synthetase activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0005524">
    <property type="term" value="F:ATP binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0003725">
    <property type="term" value="F:double-stranded RNA binding"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0046872">
    <property type="term" value="F:metal ion binding"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0042742">
    <property type="term" value="P:defense response to bacterium"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0051607">
    <property type="term" value="P:defense response to virus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045087">
    <property type="term" value="P:innate immune response"/>
    <property type="evidence" value="ECO:0007669"/>
    <property type="project" value="UniProtKB-KW"/>
  </dbReference>
  <dbReference type="GO" id="GO:0039530">
    <property type="term" value="P:MDA-5 signaling pathway"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071650">
    <property type="term" value="P:negative regulation of chemokine (C-C motif) ligand 5 production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:2000342">
    <property type="term" value="P:negative regulation of chemokine (C-X-C motif) ligand 2 production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0035395">
    <property type="term" value="P:negative regulation of chemokine (C-X-C motif) ligand 9 production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071659">
    <property type="term" value="P:negative regulation of IP-10 production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060339">
    <property type="term" value="P:negative regulation of type I interferon-mediated signaling pathway"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0045071">
    <property type="term" value="P:negative regulation of viral genome replication"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0006139">
    <property type="term" value="P:nucleobase-containing compound metabolic process"/>
    <property type="evidence" value="ECO:0000304"/>
    <property type="project" value="ProtInc"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032728">
    <property type="term" value="P:positive regulation of interferon-beta production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0071639">
    <property type="term" value="P:positive regulation of monocyte chemotactic protein-1 production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0032760">
    <property type="term" value="P:positive regulation of tumor necrosis factor production"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="GO" id="GO:0060700">
    <property type="term" value="P:regulation of ribonuclease activity"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0009615">
    <property type="term" value="P:response to virus"/>
    <property type="evidence" value="ECO:0000314"/>
    <property type="project" value="UniProtKB"/>
  </dbReference>
  <dbReference type="GO" id="GO:0039529">
    <property type="term" value="P:RIG-I signaling pathway"/>
    <property type="evidence" value="ECO:0000315"/>
    <property type="project" value="ARUK-UCL"/>
  </dbReference>
  <dbReference type="CDD" id="cd05400">
    <property type="entry name" value="NT_2-5OAS_ClassI-CCAase"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="Gene3D" id="1.10.1410.20">
    <property type="entry name" value="2'-5'-oligoadenylate synthetase 1, domain 2"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="Gene3D" id="3.30.460.10">
    <property type="entry name" value="Beta Polymerase, domain 2"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR018952">
    <property type="entry name" value="2-5-oligoAdlate_synth_1_dom2/C"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR006117">
    <property type="entry name" value="2-5OAS_C_CS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR043518">
    <property type="entry name" value="2-5OAS_N_CS"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR006116">
    <property type="entry name" value="NT_2-5OAS_ClassI-CCAase"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR043519">
    <property type="entry name" value="NT_sf"/>
  </dbReference>
  <dbReference type="InterPro" id="IPR002934">
    <property type="entry name" value="Polymerase_NTP_transf_dom"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR11258:SF7">
    <property type="entry name" value="2'-5'-OLIGOADENYLATE SYNTHASE-LIKE PROTEIN 2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="PANTHER" id="PTHR11258">
    <property type="entry name" value="2-5 OLIGOADENYLATE SYNTHETASE"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF01909">
    <property type="entry name" value="NTP_transf_2"/>
    <property type="match status" value="1"/>
  </dbReference>
  <dbReference type="Pfam" id="PF10421">
    <property type="entry name" value="OAS1_C"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF81301">
    <property type="entry name" value="Nucleotidyltransferase"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="SUPFAM" id="SSF81631">
    <property type="entry name" value="PAP/OAS1 substrate-binding domain"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00832">
    <property type="entry name" value="25A_SYNTH_1"/>
    <property type="match status" value="3"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS00833">
    <property type="entry name" value="25A_SYNTH_2"/>
    <property type="match status" value="2"/>
  </dbReference>
  <dbReference type="PROSITE" id="PS50152">
    <property type="entry name" value="25A_SYNTH_3"/>
    <property type="match status" value="3"/>
  </dbReference>
  <proteinExistence type="evidence at protein level"/>
  <keyword id="KW-0002">3D-structure</keyword>
  <keyword id="KW-0007">Acetylation</keyword>
  <keyword id="KW-0051">Antiviral defense</keyword>
  <keyword id="KW-0067">ATP-binding</keyword>
  <keyword id="KW-0963">Cytoplasm</keyword>
  <keyword id="KW-0903">Direct protein sequencing</keyword>
  <keyword id="KW-0391">Immunity</keyword>
  <keyword id="KW-0399">Innate immunity</keyword>
  <keyword id="KW-0460">Magnesium</keyword>
  <keyword id="KW-0479">Metal-binding</keyword>
  <keyword id="KW-0547">Nucleotide-binding</keyword>
  <keyword id="KW-0548">Nucleotidyltransferase</keyword>
  <keyword id="KW-0539">Nucleus</keyword>
  <keyword id="KW-0597">Phosphoprotein</keyword>
  <keyword id="KW-1267">Proteomics identification</keyword>
  <keyword id="KW-1185">Reference proteome</keyword>
  <keyword id="KW-0677">Repeat</keyword>
  <keyword id="KW-0694">RNA-binding</keyword>
  <keyword id="KW-0808">Transferase</keyword>
  <feature type="chain" id="PRO_0000160265" description="2'-5'-oligoadenylate synthase 3">
    <location>
      <begin position="1"/>
      <end position="1087"/>
    </location>
  </feature>
  <feature type="region of interest" description="OAS domain 1" evidence="10">
    <location>
      <begin position="6"/>
      <end position="343"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with dsRNA" evidence="7">
    <location>
      <begin position="12"/>
      <end position="57"/>
    </location>
  </feature>
  <feature type="region of interest" description="Interaction with dsRNA" evidence="7">
    <location>
      <begin position="186"/>
      <end position="200"/>
    </location>
  </feature>
  <feature type="region of interest" description="Linker" evidence="10">
    <location>
      <begin position="344"/>
      <end position="410"/>
    </location>
  </feature>
  <feature type="region of interest" description="OAS domain 2" evidence="10">
    <location>
      <begin position="411"/>
      <end position="742"/>
    </location>
  </feature>
  <feature type="region of interest" description="OAS domain 3" evidence="10">
    <location>
      <begin position="750"/>
      <end position="1084"/>
    </location>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="804"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="11">
    <location>
      <position position="816"/>
    </location>
    <ligand>
      <name>Mg(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:18420"/>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="11">
    <location>
      <position position="818"/>
    </location>
    <ligand>
      <name>Mg(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:18420"/>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="888"/>
    </location>
    <ligand>
      <name>Mg(2+)</name>
      <dbReference type="ChEBI" id="CHEBI:18420"/>
      <note>catalytic</note>
    </ligand>
  </feature>
  <feature type="binding site" evidence="2">
    <location>
      <position position="947"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="950"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="binding site" evidence="1">
    <location>
      <position position="969"/>
    </location>
    <ligand>
      <name>ATP</name>
      <dbReference type="ChEBI" id="CHEBI:30616"/>
    </ligand>
  </feature>
  <feature type="site" description="Interaction with dsRNA" evidence="7">
    <location>
      <position position="155"/>
    </location>
  </feature>
  <feature type="site" description="Interaction with dsRNA" evidence="7">
    <location>
      <position position="244"/>
    </location>
  </feature>
  <feature type="modified residue" description="N-acetylmethionine" evidence="9 13">
    <location>
      <position position="1"/>
    </location>
  </feature>
  <feature type="modified residue" description="Phosphothreonine" evidence="14">
    <location>
      <position position="365"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_060076" description="In dbSNP:rs1859330." evidence="3">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="18"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_060077" description="In dbSNP:rs1859330.">
    <original>R</original>
    <variation>M</variation>
    <location>
      <position position="18"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_060078" description="In dbSNP:rs1859330.">
    <original>R</original>
    <variation>T</variation>
    <location>
      <position position="18"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_057660" description="In dbSNP:rs12819767.">
    <original>R</original>
    <variation>W</variation>
    <location>
      <position position="65"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_062127" description="In dbSNP:rs45519442.">
    <original>R</original>
    <variation>K</variation>
    <location>
      <position position="378"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_057661" description="In dbSNP:rs2285933." evidence="4">
    <original>S</original>
    <variation>R</variation>
    <location>
      <position position="381"/>
    </location>
  </feature>
  <feature type="sequence variant" id="VAR_057662" description="In dbSNP:rs16942374.">
    <original>R</original>
    <variation>H</variation>
    <location>
      <position position="869"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impaired dsRNA binding." evidence="7">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="30"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Impaired dsRNA binding." evidence="7">
    <original>R</original>
    <variation>A</variation>
    <location>
      <position position="41"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on catalytic activity; when associated with D-145." evidence="7">
    <original>E</original>
    <variation>D</variation>
    <location>
      <position position="76"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="No effect on catalytic activity. No effect on catalytic activity; when associated with D-76." evidence="7">
    <original>S</original>
    <variation>D</variation>
    <location>
      <position position="145"/>
    </location>
  </feature>
  <feature type="mutagenesis site" description="Abolishes catalytic activity." evidence="7">
    <original>DAD</original>
    <variation>AAA</variation>
    <location>
      <begin position="816"/>
      <end position="818"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD28543." evidence="10" ref="1">
    <original>G</original>
    <variation>A</variation>
    <location>
      <position position="159"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD28543." evidence="10" ref="1">
    <original>A</original>
    <variation>G</variation>
    <location>
      <position position="249"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD28543." evidence="10" ref="1">
    <original>QL</original>
    <variation>HV</variation>
    <location>
      <begin position="287"/>
      <end position="288"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD28543." evidence="10" ref="1">
    <original>L</original>
    <variation>H</variation>
    <location>
      <position position="316"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD28543." evidence="10" ref="1">
    <original>G</original>
    <variation>A</variation>
    <location>
      <position position="393"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 1; AAD28543 and 2; BAB18647." evidence="10" ref="1 2">
    <original>QL</original>
    <variation>HV</variation>
    <location>
      <begin position="503"/>
      <end position="504"/>
    </location>
  </feature>
  <feature type="sequence conflict" description="In Ref. 2; BAB18647." evidence="10" ref="2">
    <original>G</original>
    <variation>R</variation>
    <location>
      <position position="984"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="2"/>
      <end position="5"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="8"/>
      <end position="10"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="11"/>
      <end position="18"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="23"/>
      <end position="41"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="54"/>
      <end position="60"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="61"/>
      <end position="65"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="73"/>
      <end position="81"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="89"/>
      <end position="92"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="95"/>
      <end position="108"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="116"/>
      <end position="119"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="129"/>
      <end position="139"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="141"/>
      <end position="149"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="165"/>
      <end position="172"/>
    </location>
  </feature>
  <feature type="turn" evidence="15">
    <location>
      <begin position="177"/>
      <end position="180"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="181"/>
      <end position="184"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="185"/>
      <end position="193"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="197"/>
      <end position="215"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="226"/>
      <end position="240"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="248"/>
      <end position="260"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="262"/>
      <end position="264"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="275"/>
      <end position="277"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="278"/>
      <end position="288"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="290"/>
      <end position="292"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="294"/>
      <end position="296"/>
    </location>
  </feature>
  <feature type="strand" evidence="15">
    <location>
      <begin position="304"/>
      <end position="306"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="313"/>
      <end position="322"/>
    </location>
  </feature>
  <feature type="helix" evidence="15">
    <location>
      <begin position="327"/>
      <end position="329"/>
    </location>
  </feature>
  <feature type="turn" evidence="15">
    <location>
      <begin position="332"/>
      <end position="334"/>
    </location>
  </feature>
  <evidence type="ECO:0000250" key="1">
    <source>
      <dbReference type="UniProtKB" id="P00973"/>
    </source>
  </evidence>
  <evidence type="ECO:0000250" key="2">
    <source>
      <dbReference type="UniProtKB" id="P29728"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="3">
    <source>
      <dbReference type="PubMed" id="11280764"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="4">
    <source>
      <dbReference type="PubMed" id="15489334"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="5">
    <source>
      <dbReference type="PubMed" id="19056102"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="6">
    <source>
      <dbReference type="PubMed" id="19923450"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="7">
    <source>
      <dbReference type="PubMed" id="25775560"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="8">
    <source>
      <dbReference type="PubMed" id="9880533"/>
    </source>
  </evidence>
  <evidence type="ECO:0000269" key="9">
    <source ref="6"/>
  </evidence>
  <evidence type="ECO:0000305" key="10"/>
  <evidence type="ECO:0000305" key="11">
    <source>
      <dbReference type="PubMed" id="25775560"/>
    </source>
  </evidence>
  <evidence type="ECO:0000305" key="12">
    <source>
      <dbReference type="PubMed" id="9880533"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="13">
    <source>
      <dbReference type="PubMed" id="22814378"/>
    </source>
  </evidence>
  <evidence type="ECO:0007744" key="14">
    <source>
      <dbReference type="PubMed" id="23186163"/>
    </source>
  </evidence>
  <evidence type="ECO:0007829" key="15">
    <source>
      <dbReference type="PDB" id="4S3N"/>
    </source>
  </evidence>
  <sequence length="1087" mass="121170" checksum="36DAADE4574DE961" modified="2011-01-11" version="3">MDLYSTPAAALDRFVARRLQPRKEFVEKARRALGALAAALRERGGRLGAAAPRVLKTVKGGSSGRGTALKGGCDSELVIFLDCFKSYVDQRARRAEILSEMRASLESWWQNPVPGLRLTFPEQSVPGALQFRLTSVDLEDWMDVSLVPAFNVLGQAGSGVKPKPQVYSTLLNSGCQGGEHAACFTELRRNFVNIRPAKLKNLILLVKHWYHQVCLQGLWKETLPPVYALELLTIFAWEQGCKKDAFSLAEGLRTVLGLIQQHQHLCVFWTVNYGFEDPAVGQFLQRQLKRPRPVILDPADPTWDLGNGAAWHWDLLAQEAASCYDHPCFLRGMGDPVQSWKGPGLPRAGCSGLGHPIQLDPNQKTPENSKSLNAVYPRAGSKPPSCPAPGPTGAASIVPSVPGMALDLSQIPTKELDRFIQDHLKPSPQFQEQVKKAIDIILRCLHENCVHKASRVSKGGSFGRGTDLRDGCDVELIIFLNCFTDYKDQGPRRAEILDEMRAQLESWWQDQVPSLSLQFPEQNVPEALQFQLVSTALKSWTDVSLLPAFDAVGQLSSGTKPNPQVYSRLLTSGCQEGEHKACFAELRRNFMNIRPVKLKNLILLVKHWYRQVAAQNKGKGPAPASLPPAYALELLTIFAWEQGCRQDCFNMAQGFRTVLGLVQQHQQLCVYWTVNYSTEDPAMRMHLLGQLRKPRPLVLDPADPTWNVGHGSWELLAQEAAALGMQACFLSRDGTSVQPWDVMPALLYQTPAGDLDKFISEFLQPNRQFLAQVNKAVDTICSFLKENCFRNSPIKVIKVVKGGSSAKGTALRGRSDADLVVFLSCFSQFTEQGNKRAEIISEIRAQLEACQQERQFEVKFEVSKWENPRVLSFSLTSQTMLDQSVDFDVLPAFDALGQLVSGSRPSSQVYVDLIHSYSNAGEYSTCFTELQRDFIISRPTKLKSLIRLVKHWYQQCTKISKGRGSLPPQHGLELLTVYAWEQGGKDSQFNMAEGFRTVLELVTQYRQLCIYWTINYNAKDKTVGDFLKQQLQKPRPIILDPADPTGNLGHNARWDLLAKEAAACTSALCCMGRNGIPIQPWPVKAAV</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>